<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001585545</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000913142</issuerCik>
      <issuerName>BELDEN INC.</issuerName>
      <secFileNumber>001-12561</secFileNumber>
      <issuerAddress>
        <com:street1>1 NORTH BRENTWOOD BLVD</com:street1>
        <com:street2>15TH FLOOR</com:street2>
        <com:city>ST. LOUIS</com:city>
        <com:stateOrCountry>MO</com:stateOrCountry>
        <com:zipCode>63105</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>314-854-8000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Zink Doug</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>RAYMOND JAMES &amp; ASSOCIATES INC</name>
        <address>
          <com:street1>880 CARILLON PKWY</com:street1>
          <com:city>ST. PETERSBURG</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33716</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2350</noOfUnitsSold>
      <aggregateMarketValue>220919.51</aggregateMarketValue>
      <noOfUnitsOutstanding>42550000</noOfUnitsOutstanding>
      <approxSaleDate>06/07/2023</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>03/04/2016</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>578</amountOfSecuritiesAcquired>
      <paymentDate>03/04/2016</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>02/25/2017</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>569</amountOfSecuritiesAcquired>
      <paymentDate>02/25/2017</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>03/04/2017</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>262</amountOfSecuritiesAcquired>
      <paymentDate>03/04/2017</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>02/25/2018</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>218</amountOfSecuritiesAcquired>
      <paymentDate>02/25/2018</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>02/24/2019</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>461</amountOfSecuritiesAcquired>
      <paymentDate>02/24/2019</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>02/22/2020</acquiredDate>
      <natureOfAcquisitionTransaction>SARS SHARES GRANT</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>262</amountOfSecuritiesAcquired>
      <paymentDate>02/22/2020</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/07/2023</noticeDate>
      <signature>MOHAMMED ALSHATRI, as duly authorized representative of Raymond James &amp; Associates, Inc., as attorney-in-fact for DOUG ZINK</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
